Global Biotech and Pharma Licencing Activity Value Rebounds in Q4 2009
After decreasing the last three quarters, the value of drug licensing agreements has gone past the Q4 2008 mark of US$10,963m by US$6,435m according to BioPharm Insight report.
After decreasing the last three quarters, the value of drug licensing agreements has gone past the Q4 2008 mark of US$10,963m by US$6,435m according to BioPharm Insight report.
Market Leader provides new intelligence to extend its reach into clinical operations at its biotech, pharmaceutical, CRO and service provider clients.
BioPharm Insight™ by Infinata, a leading provider of life science industry information and insight, today announced a significant enhancement to their BioPharm Insight online database product. The latest release of BioPharm Insight includes new licensing agreement content and a new search, enabling users to gain easy access to this content.
Newest BioPharm insight release adds forward-looking coverage into the most important situations taking place in the Biotech and Pharma Industry.
The Clinical Trial Company (Knutsford, UK) and The Clinical Trial Company Canada; TCTC are pleased to announce their Quality Management System has achieved ISO9001:2008 accreditation.
The Clinical Trial Company (Knutsford, UK) are pleased to announce that they will be attending the 31st Annual Institute of Clinical Research Conference and Exhibition.
2010 creativity awards program recipients plan diverse applications including food safety monitoring and analysis of blood platelet disorders. Rapid uptake by scientists worldwide is testament to the mix of performance, ease-of-use and cost-effectiveness of the Accuri C6 Flow Cytometer.
The Clinical Trial Company TCTC are pleased to announce that they will attend the Clinical Trials Congress, to be held at the JW Marriott, Mumbai, India from 20th to 22nd January 2010.
Brings together Accuri's breakthrough flow cytometer and eBioscience's leading flow cytometry reagents to offer researchers a better solution. Collaboration combines performance, ease-of-use and cost-effectiveness of the Accuri C6 Flow Cytometer and high quality, extensive reagent collection from eBioscience.
Increasing support to clinical trials in emerging Asian markets and offering cost savings to clients worldwide.